Lentiviral-mediated gene therapy for Fanconi anemia A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lentiviral-mediated gene therapy for Fanconi anemia A, covering 2024-05-22 to 2024-05-22. Get the full timeline:
Most recent: Clinical Trial Update: Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A [Phase 2]